Bell J - Search Results

1

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, Rose GS, Spirtos NM; Gynecologic Oncology Group. Bell J, et al. Gynecol Oncol. 2006 Sep;102(3):432-9. doi: 10.1016/j.ygyno.2006.06.013. Epub 2006 Jul 24. Gynecol Oncol. 2006. PMID: 16860852 Clinical Trial.

2

Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon.

Markman M, Berek JS, Blessing JA, McGuire WP, Bell J, Homesley HD. Markman M, et al. Among authors: bell j. Gynecol Oncol. 1992 Apr;45(1):3-8. doi: 10.1016/0090-8258(92)90482-x. Gynecol Oncol. 1992. PMID: 1601332 Clinical Trial.

3

5-year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma.

Lovecchio JL, Averette HE, Donato D, Bell J. Lovecchio JL, et al. Among authors: bell j. Gynecol Oncol. 1989 Jul;34(1):43-5. doi: 10.1016/0090-8258(89)90103-0. Gynecol Oncol. 1989. PMID: 2737524

4

Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.

Bell JG, Minnick A, Reid GC, Judis J, Brownell M. Bell JG, et al. Gynecol Oncol. 1997 Sep;66(3):388-92. doi: 10.1006/gyno.1997.4788. Gynecol Oncol. 1997. PMID: 9299250

5

Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma.

Bell JG, Lea JS, Reid GC. Bell JG, et al. Gynecol Oncol. 2000 May;77(2):314-8. doi: 10.1006/gyno.2000.5790. Gynecol Oncol. 2000. PMID: 10785485

6

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Rose PG, Brunetto VL, VanLe L, Bell J, Walker JL, Lee RB. Rose PG, et al. Among authors: bell j. Gynecol Oncol. 2000 Aug;78(2):212-6. doi: 10.1006/gyno.2000.5865. Gynecol Oncol. 2000. PMID: 10926805 Clinical Trial.

7

Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

Thigpen T, Brady MF, Homesley HD, Soper JT, Bell J. Thigpen T, et al. Among authors: bell j. J Clin Oncol. 2001 Jan 15;19(2):364-7. doi: 10.1200/JCO.2001.19.2.364. J Clin Oncol. 2001. PMID: 11208827 Clinical Trial.

8

Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment.

Heddens D, Alberts DS, Hannigan EV, Williams SD, Garcia D, Roe DJ, Bell J, Alvarez RD. Heddens D, et al. Among authors: bell j. Gynecol Oncol. 2002 Sep;86(3):239-43. doi: 10.1006/gyno.2002.6726. Gynecol Oncol. 2002. PMID: 12217742

9

Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.

Thigpen JT, Blessing JA, Olt G, Lentz SS, Bell J. Thigpen JT, et al. Among authors: bell j. Gynecol Oncol. 2003 Sep;90(3):581-6. doi: 10.1016/s0090-8258(03)00327-5. Gynecol Oncol. 2003. PMID: 13678728 Clinical Trial.

10

Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Havrilesky L, Darcy kM, Hamdan H, Priore RL, Leon J, Bell J, Berchuck A; Gynecologic Oncology Group Study. Havrilesky L, et al. Among authors: bell j. J Clin Oncol. 2003 Oct 15;21(20):3814-25. doi: 10.1200/JCO.2003.11.052. J Clin Oncol. 2003. PMID: 14551300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,280 results

Search Page

Filters